The biotech firm reported on Monday that the vaccine produced protective antibodies in all eight of its volunteers, potentially marking a breakthrough moment in the fight against the coronavirus pandemic."All companies searching for a vaccine like to say they are doing well: it's very much in their interest. This was a sample of less than 10 when phase two, starting in months, will be on many thousands," analysts at Rabobank said in a note.
"Even if that hurdle is passed with flying colors we will still not see a vaccine on the US market, let alone in emerging markets, until early 2021."Asian indexes climbed with China's Shanghai Composite up 0.8%, Hong Kong's
Chennylou 🙏🏾
Grabbing at straws
United States United States Latest News, United States United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: USATODAY - 🏆 100. / 63 Read more »